{"id":"NCT01197755","sponsor":"AstraZeneca","briefTitle":"Evaluation of Effectiveness of Two Dosing Regimens of Fostamatinib Compared to Placebo in Patients With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate and Have Had Inadequate Response to Single TNF-alpha Antagonist","officialTitle":"(OSKIRA-3): A Phase III, Multi-centre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study of Two Dosing Regimens of Fostamatinib Disodium in Rheumatoid Arthritis Patients With Inadequate Response to a TNF-alpha Antagonist","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-09","primaryCompletion":"2013-02","completion":"2013-02","firstPosted":"2010-09-09","resultsPosted":"2014-04-07","lastUpdate":"2014-04-07"},"enrollment":323,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Rheumatoid Arthritis"],"interventions":[{"type":"DRUG","name":"fostamatinib","otherNames":[]},{"type":"DRUG","name":"fostamatinib","otherNames":[]},{"type":"DRUG","name":"placebo","otherNames":[]}],"arms":[{"label":"Dosing Regimen A","type":"EXPERIMENTAL"},{"label":"Dosing Regimen B","type":"EXPERIMENTAL"},{"label":"Dosing Regimen C","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of the study is to evaluate the effectiveness of two dosing regimens of fostamatinib compared to placebo, in patients with rheumatoid arthritis (RA) who are taking methotrexate and have had an inadequate response to a single TNF-alpha antagonist. The study will last for approximately six months.","primaryOutcome":{"measure":"Proportion of Patients Achieving ACR20 at Week 24, Comparison Between Fostamatinib and Placebo","timeFrame":"24 weeks","effectByArm":[{"arm":"FOSTA 100 MG BID PO","deltaMin":36.2,"sd":null},{"arm":"FOSTA 100 MG BID (4 WKS) THEN 150 MG QD PO","deltaMin":27.8,"sd":null},{"arm":"PLACEBO PO","deltaMin":21.1,"sd":null}],"pValues":[{"comp":"OG000 vs OG002","p":"0.004"},{"comp":"OG001 vs OG002","p":"0.168"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":9},"locations":{"siteCount":135,"countries":["United States","Argentina","Belgium","Brazil","Canada","Czechia","France","Germany","Hungary","Israel","Italy","Mexico","Portugal","South Africa","Spain","United Kingdom"]},"refs":{"pmids":[],"seeAlso":["http://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_6111&studyid=419&filename=CSR-D8480C00030.pdf","http://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_6111&studyid=1201&filename=CSR-D1700C00001.pdf"]},"adverseEventsSummary":{"seriousAny":{"events":7,"n":105},"commonTop":["DIARRHOEA","HYPERTENSION","HEADACHE","RHEUMATOID ARTHRITIS","NAUSEA"]}}